Immune gene linked to prostate cancer
Scientists analyzing the DNA of families whose men are prone to prostate cancer have found a mutated gene that predisposes them to the disease. It’s still unclear how often a mutation in this gene leads to the cancer in men with no family history of the disease, who make up the majority of cases.
The gene encodes a protein that sits on the surface of immune cells called macrophages. Known as a scavenger receptor, the protein binds to a variety of fat-bearing molecules and has been previously associated with hardening of the arteries and heart disease.
A 31-member team of researchers led by Jianfeng Xu of Wake Forest University School of Medicine in Winston-Salem, N.C., took a close look at the immune system gene because it’s in a chromosomal region that past studies had linked to prostate cancer. Moreover, there has been some evidence that sexually transmitted infections and aberrant macrophage activity predispose men to prostate cancer.
In a study to be reported in an upcoming Nature Genetics, the investigators observed mutations in the macrophage gene in the men with prostate cancer from 13 of the 190 cancer-prone families being studied. As a follow-up, the researchers did a preliminary survey of men without a family history of the disease. They found that the gene is mutated in up to 12.5 percent of men with prostate cancer and up to 1.8 percent of unaffected men.
If you have a comment on this article that you would like considered for publication in Science News, please send it to firstname.lastname@example.org.